package Insulin Resistance allows you to assess the sensitivity of tissues to insulin – a key hormone in transporting glucose into cells.
Insulin resistance is a condition of reduced tissue sensitivity to insulin caused by genetic predisposition, hormonal imbalances, and obesity. This can ultimately lead to the development of metabolic syndrome and type 2 diabetes. This package should be completed by individuals experiencing recurring symptoms such as chronic fatigue, increased thirst, post-meal drowsiness, a strong craving for sweets, difficulty maintaining a healthy weight, and hypertension. The degree of insulin resistance is determined by the HOMA IR index, calculated based on fasting glucose and insulin results – the higher the value, the greater the risk of metabolic disorders.
This test should be performed in individuals with obesity, dyslipidemia, hypertension, polycystic ovary syndrome, and in individuals at risk for diabetes or metabolic syndrome to determine cardiovascular risk. The Homa IR index should be measured three to four times to determine insulin resistance.
The test involves measuring fasting glucose and insulin levels. The resulting value indicates the severity of changes – the higher the result, the greater the insulin resistance. In a healthy person, a Homa IR of approximately 1 indicates normal tissue sensitivity to insulin. Values above 2.5 may indicate insulin resistance.
The indicator is not useful in people diagnosed with diabetes.